1OR2 | Lipid Binding Protein | date | Mar 25, 1999 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Apolipoprotein E3 (Apoe3) Truncation Mutant 165 | ||||||||||||||
authors | B.Rupp, B.W.Segelke, M.Forstner | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Apolipoprotein E Chain: A Fragment: Receptor Binding Domain, Residues 1-165 Synonym: Apoe3 Engineered: Yes Mutation: Yes Other_details: Selenomethionine Mutant Used In Mad Phasing |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Strain: B834(De)Met- Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: B834(De)Met- Expression_system_plasmid: Pet | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.50 Å | ||||||||||||
ligand | MSE | enzyme |
| ||||||||||||
related structures | by homologous chain: 1LE2, 1LE4 | ||||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: implications for lipid binding., Segelke BW, Forstner M, Knapp M, Trakhanov SD, Parkin S, Newhouse YM, Bellamy HD, Weisgraber KH, Rupp B, Protein Sci 2000 May;9(5):886-97. PMID:10850798 |
Data retrieval |
View 1OR2 in 3D |
Visual 3D analysis of 1OR2 |
Structure-derived information |
- Domain d1or2a_, region A [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1OR2 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |